Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuven Mader

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|February 10, 2023
Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide settingAmir Bieber, Shay Brikman, Lena Novack, et al.
Harefuah|February 4, 2014
[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome]Jacob N Ablin, Howard Amital, Michael Ehrenfeld, et al.
Medicine|December 20, 2023
IgA vasculitis in adults, pediatrics and non-vasculitic IgA nephropathy, retrospective analysis from 2 centersShirel Levanon, Vera Gotloib, Yehudit Kraus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicityGal Markel, Niva Lieberman, Gil Katz, et al.
RMD Open|September 29, 2017
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go nextReuven Mader, Jorrit-Jan Verlaan, Iris Eshed, et al.
Clinical Rheumatology|March 2, 2011
Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosisGleb Slobodin, Iris Reyhan, Nina Avshovich, et al.
International Immunology|June 7, 2005
The involvement of NK cells in ankylosing spondylitisNiva Azuz-Lieberman, Gal Markel, Sa'ar Mizrahi, et al.
Current Rheumatology Reports|January 26, 2021
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory ComponentReuven Mader, Nicola Pappone, Xenofon Baraliakos, et al.
The Israel Medical Association Journal : IMAJ|April 10, 2018
Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid ArthritisMahmoud Abu-Shakra, Devy Zisman, Alexandra Balbir-Gurman, et al.
Rheumatology (Oxford, England)|April 4, 2017
Classification criteria for diffuse idiopathic skeletal hyperostosis: a lack of consensusJonneke S Kuperus, Erin E A de Gendt, F Cumhur Oner, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|February 10, 2023
Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide settingAmir Bieber, Shay Brikman, Lena Novack, et al.
Harefuah|February 4, 2014
[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome]Jacob N Ablin, Howard Amital, Michael Ehrenfeld, et al.
Medicine|December 20, 2023
IgA vasculitis in adults, pediatrics and non-vasculitic IgA nephropathy, retrospective analysis from 2 centersShirel Levanon, Vera Gotloib, Yehudit Kraus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicityGal Markel, Niva Lieberman, Gil Katz, et al.
RMD Open|September 29, 2017
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go nextReuven Mader, Jorrit-Jan Verlaan, Iris Eshed, et al.
Clinical Rheumatology|March 2, 2011
Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosisGleb Slobodin, Iris Reyhan, Nina Avshovich, et al.
International Immunology|June 7, 2005
The involvement of NK cells in ankylosing spondylitisNiva Azuz-Lieberman, Gal Markel, Sa'ar Mizrahi, et al.
Current Rheumatology Reports|January 26, 2021
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory ComponentReuven Mader, Nicola Pappone, Xenofon Baraliakos, et al.
The Israel Medical Association Journal : IMAJ|April 10, 2018
Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid ArthritisMahmoud Abu-Shakra, Devy Zisman, Alexandra Balbir-Gurman, et al.
Rheumatology (Oxford, England)|April 4, 2017
Classification criteria for diffuse idiopathic skeletal hyperostosis: a lack of consensusJonneke S Kuperus, Erin E A de Gendt, F Cumhur Oner, et al.
Pageof 7